Mansour H Almatarneh

Prof. Mansour H Almatarneh


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MUMohammed Kabir Uddin
Mohammed Kabir Uddin
MAMansour H Almatarneh
Mansour H Almatarneh
RPRaymond A. Poirier
Raymond A. Poirier
MUMohammed Kabir Uddin
Mohammed Kabir Uddin
Cancer remains one of the leading causes of death globally, highlighting the urgent need for novel anticancer therapies with higher efficacy and reduced toxicity. Similarly, the rise in multidrug-resistant pathogens and emerging infectious diseases underscores the critical demand for new antimicrobial agents that target resistant infections through unique mechanisms. This study used computational approaches to investigate twenty quinolone–triazole and conazole–triazole hybrid derivatives as antimicrobial and anticancer agents (1–20) with nine reference drugs. By studying their interactions with 6 bacterial DNA gyrase and 10 cancer-inducing target proteins (E. faecalis, M. tuberculosis, S. aureus, E. coli, M. smegmatis, P. aeruginosa and EGFR, MPO, VEGFR, CDK6, MMP1, Bcl-2, LSD1, HDAC6, Aromatase, ALOX15) and comparing them with established drugs such as ampicillin, cefatrizine, fluconazole, gemcitabine, itraconazole, ribavirin, rufinamide, streptomycin, and tazobactam, compounds 15 and 16 emerged as noteworthy antimicrobial and anticancer agents, respectively. In molecular dynamics simulations, compounds 15 and 16 had the strongest binding at −10.6 kcal mol−1 and −12.0 kcal mol−1 with the crucial 5CDQ and 2Z3Y proteins, respectively, exceeded drug-likeness criteria, and displayed extraordinary stability within the enzyme’s pocket over varied temperatures (300–320 K). In addition, we used density functional theory (DFT) to calculate dipole moments and molecular orbital characteristics and analyze the thermodynamic stability of putative antimicrobial and anticancer derivatives. This finding reveals a well-defined, possibly therapeutic relationship, supported by theoretical and future in vitro and in vivo studies. Compounds 15 and 16, thus, emerged as intriguing contenders in the fight against infectious diseases and cancer.

21 January 2026 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
MMMehnaz H Meem
Mehnaz H Meem
MAMansour H Almatarneh
Mansour H Almatarneh
SASahar Abdalla
Sahar Abdalla
IJIsmat Ruh Jahan
Ismat Ruh Jahan
TKTafsir Karim
Tafsir Karim
MUMohammed Kabir Uddin
Mohammed Kabir Uddin
Malaria, caused by Plasmodium falciparum , remains a major global health challenge, exacerbated by increasing resistance to frontline therapies. This computational study evaluated 43 quinoline-4-carboxamide derivatives ( 1-43 ) against validated P. falciparum and human off-target proteins. Molecular docking identified ligand 24 as the most potent inhibitor of P. falciparum aminopeptidase N (3EBH; −10.3 kcal mol⁻ 1 ), outperforming chloroquine and quinine (−8.3 kcal mol⁻ 1 ). Ligand 24 complied with Lipinski and Veber drug-likeness rules, exhibited favorable ADMET (absorption, distribution, metabolism, excretion, toxicity) properties (clogP = 2.3, TPSA = 92 Å 2 , hERG pIC₅₀ = 0.79), and showed no predicted toxicity alerts. Molecular-dynamics simulations (20 ns) across 300-320 K confirmed stable interactions within the 3EBH-ligand 24 complex, with optimal stability at 310 K (root mean square deviation-RMSD <0.3 nm). Principal-component analysis (PCA) further indicated reliable conformational sampling (PC1 variance 60.8%, cosine content 0.36). Comparative profiling established ligand 24 as the leading candidate, integrating strong binding affinity with favorable pharmacokinetic and safety profiles. Ligand 7 also displayed promising electronic features. These findings collectively designate ligand 24 as a priority scaffold for experimental validation toward developing novel antimalarial therapeutics.

10 February 2026 in Journal of King Saud University – Science
Verified
Journal Article
Open access
PDF file
HSHumaera Noor Suha
Humaera Noor Suha
MAMansour H Almatarneh
Mansour H Almatarneh
RARatul
Ratul
ABAhsan Ul Bari
Ahsan Ul Bari
MAMamduh J. Aljaafreh
Mamduh J. Aljaafreh
MUMohammed Kabir Uddin
Mohammed Kabir Uddin
Cancer remains a major global health challenge due to uncontrolled cell proliferation and metastasis. This study aimed to investigate 14 newly synthesized phenothiazine derivatives as potential anticancer agents, focusing on cyclin-dependent kinase 2 (CDK2, PDB: 1CKP) and aromatase (PDB: 4KQ8) as therapeutic targets. A comprehensive computational strategy was applied, including density functional theory (DFT) calculations at B3LYP/6-31G(d,p) in gas phase, molecular docking using docking engine AutoDock Vina, molecular dynamics (MD) simulations for 100 ns, binding force analyses, drug-likeness and ADMET (absorption, distribution, metabolism, excretion, and toxicity) predictions, and frontier molecular orbital (FMO) (highest occupied molecular orbital (HOMO)-lowest unoccupied molecular orbital (LUMO)) assessments. Standard anticancer agents, tamoxifen, doxorubicin, letrozole, and flavopiridol, were used for comparative evaluation. Among the derivatives, compound 3 (targeting aromatase with a docking score of −10.0 kcal∙mol⁻ 1 .) and compound 12 (targeting CDK2 with −10.9 kcal∙mol⁻ 1 docking score) showed the strongest binding affinities, often comparable to or exceeding those of the reference drugs. Both exhibited interaction patterns similar to tamoxifen with CDK2 and BRD4, supporting their potential as multitarget anticancer agents. All synthesized molecules fulfilled drug-likeness criteria and demonstrated mild to moderate predicted oral toxicity, appearing to possess characteristics that could support oral administration and need further investigation. Broader screening against six additional cancer-related proteins, including glucose-6-phosphate dehydrogenase (G6PD, PDB: 4D7B), aryl hydrocarbon receptor ligand-binding domain (AHR-LBD, PDB: 5D0R), glucose-regulated protein 78 (GRP78, PDB: 5F1X), and the SCF complex (PDB: 1FQV), further highlighted their therapeutic promise. This integrated computational analysis identified derivatives 3 and 12 as promising phenothiazine-based anticancer candidates with favorable drug-likeness, acceptable toxicity, and multitarget binding capacity. These findings provide a foundation for future in vivo and clinical investigations to validate their potential as inhibitors of CDK2, aromatase, and other cancer-associated proteins.

31 December 2025 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
STSyed Ahmed Tasnim
Syed Ahmed Tasnim
HSHumaera Noor Suha
Humaera Noor Suha
SNSaiyara E. Nawar
Saiyara E. Nawar
MAMansour H Almatarneh
Mansour H Almatarneh
AAAshraf M H Al-Msiedeen
Ashraf M H Al-Msiedeen
MUMohammed Kabir Uddin
Mohammed Kabir Uddin
Trimethoxyflavan derivatives 1–24 were evaluated against NSCLC via an integrated in silico approach involving molecular docking, MD simulations, MM/PBSA, DFT, and ADMET profiling to determine their structure-based therapeutic potential.